Litigation Details for Acerta Pharma B.V. v. Cipla Limited (D. Del. 2022)
✉ Email this page to a colleague
Acerta Pharma B.V. v. Cipla Limited (D. Del. 2022)
Docket | ⤷ Sign Up | Date Filed | 2022-02-04 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Gregory B. Williams |
Jury Demand | Defendant | Referred To | |
Patents | 10,167,291; 10,239,883; 10,272,083; 9,758,524; 9,796,721 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Acerta Pharma B.V. v. Cipla Limited
Biologic Drugs cited in Acerta Pharma B.V. v. Cipla Limited
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Acerta Pharma B.V. v. Cipla Limited (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-02-03 | 3 | ANDA Form | 11, 2032, 9,796,721 - July 1, 2036, 10,167,291 - July 1, 2036, 10,272,083 January 21, 2035. Thirty Month… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …earlier than December 29, 2021. Date of Expiration of Patent: 9,758,524 - July 11, 2032, 10,239,883- July 11… 4 February 2022 1:22-cv-00162 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
2022-02-03 | 4 | Patent/Trademark Report to Commissioner of Patents | 10,239,883 ;9,796,721 ;10,167,291 ;10,272,083. (srs) (Entered: 02/04/2022) 4 February 2022 PACER… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,758,524 ;10,… 4 February 2022 1:22-cv-00162 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |